These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29378685)

  • 41. Localized Gastroesophageal Cancers: Can We Shift the Current Treatment Paradigms?
    Rogers JE; Trail A; Ajani JA
    J Natl Compr Canc Netw; 2022 Feb; 20(2):100-101. PubMed ID: 35130497
    [No Abstract]   [Full Text] [Related]  

  • 42. The Contemporary Management of Esophageal and Gastric Cancer.
    Sihag S; Merritt RE
    Surg Oncol Clin N Am; 2024 Jul; 33(3):xv-xvi. PubMed ID: 38789203
    [No Abstract]   [Full Text] [Related]  

  • 43. The Contemporary Management of Esophageal and Gastric Cancer.
    Pawlik TM
    Surg Oncol Clin N Am; 2024 Jul; 33(3):xiii-xiv. PubMed ID: 38789202
    [No Abstract]   [Full Text] [Related]  

  • 44. [Gastroesophageal cancer: an update on diagnosis and treatment].
    Mantziari S; Allemann P; Dayer A; Demartines N; Schäfer M
    Rev Med Suisse; 2014 Jun; 10(435):1331-6. PubMed ID: 25051595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of oesophago-gastric tumours.
    Leiper K; Morris AI
    Endoscopy; 2002 Feb; 34(2):139-45. PubMed ID: 11822009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
    Hocazade C; Özdemir N; Yazici O; Bozkaya Y; Yazılıtaş D; Toptaş Ş; Zengin N; Deren T
    Ann Nucl Med; 2015 Aug; 29(7):621-6. PubMed ID: 26008856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The concentration of trace elements in cancer patients before and after treatment].
    Nuragdyev SK
    Vopr Onkol; 1971; 17(5):7-12. PubMed ID: 5138547
    [No Abstract]   [Full Text] [Related]  

  • 48. Carcinoma of the oesophagus and gastric cardia. A retrospective study based on statistical and clinical material from Finland.
    Appelqvist P
    Acta Chir Scand Suppl; 1972; 430():1-92. PubMed ID: 4122001
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical trials referral resource. Gastric and esophageal cancers.
    Cheson BD
    Oncology (Williston Park); 1991 Oct; 5(10):71-4, 79, 83-4. PubMed ID: 1838276
    [No Abstract]   [Full Text] [Related]  

  • 50. [Ⅲ.Current and Future Aspects of Precision Medicine for Esophageal and Gastric Cancer].
    Mishima S; Shitara K
    Gan To Kagaku Ryoho; 2020 Sep; 47(9):1318-1323. PubMed ID: 33130692
    [No Abstract]   [Full Text] [Related]  

  • 51. Seom guidelines for the treatment of gastric cancer 2015.
    Martin-Richard M; Custodio A; García-Girón C; Grávalos C; Gomez C; Jimenez-Fonseca P; Manzano JL; Pericay C; Rivera F; Carrato A
    Clin Transl Oncol; 2015 Dec; 17(12):996-1004. PubMed ID: 26691658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodality treatment considerations in esophageal and gastric cancer: Are we making progress?
    Roses RE; Datta J; You YN; Boughey JC
    Bull Am Coll Surg; 2015 Jul; 100(7):63-5. PubMed ID: 26248400
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessment of gastric cancer by laparoscopy.
    Shandall A; Johnson C; Celestin LR
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1918. PubMed ID: 6234049
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessment and management of psoriasis: summary of NICE guidance.
    Samarasekera E; Sawyer L; Parnham J; Smith CH;
    BMJ; 2012 Oct; 345():e6712. PubMed ID: 23097521
    [No Abstract]   [Full Text] [Related]  

  • 55. Ring-enhancing lesion associated with radiation-induced liver disease.
    Iwasa S; Mayahara H; Tanaka T; Ito Y
    J Clin Oncol; 2013 May; 31(14):e243-4. PubMed ID: 23547082
    [No Abstract]   [Full Text] [Related]  

  • 56. Gastric and Esophageal Cancer 2017.
    Petrelli NJ
    Surg Oncol Clin N Am; 2017 Apr; 26(2):xiii-xiv. PubMed ID: 28279474
    [No Abstract]   [Full Text] [Related]  

  • 57. Gastric, esophageal, and pancreatic cancer, and rare tumors.
    Bleiberg H
    Curr Opin Oncol; 1990 Aug; 2(4):718-24. PubMed ID: 1710501
    [No Abstract]   [Full Text] [Related]  

  • 58. Faecal calprotectin as a marker for oesophago-gastric cancer.
    Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM
    Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polish consensus on treatment of gastric cancer; update 2013.
    Kulig J; Wallner G; Drews M; Frączek M; Jeziorski A; Kielan W; Kołodziejczyk P; Nasierowska-Guttmejer A; Starzyńska T; Zinkiewicz K; Krawczyk M;
    Pol Przegl Chir; 2013 Sep; 85(9):544-62. PubMed ID: 24133113
    [No Abstract]   [Full Text] [Related]  

  • 60. [Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum].
    Shimizu N; Kaminishi M
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):147-51. PubMed ID: 18536318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.